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1. Initial conditions and cumulative incidence of pelvic inflammatory disease 
(PID) 
The function for the cumulative incidence of PID cases C(t) at time point t depends for each type of 
progression (immediate progression, constant progression, progression at the end) on the specific incidence 
of PID cases and fulfils that C(0)=0. 
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where s1=S(0), s2=I1(0) and s3=I2(0) describe the initial conditions for the constant progression scenario. The 
intervention group was treated for chlamydia infections and therefore has ݏଵ ൌ 1 െ ݌ ∗ ߜ, ݏଶ ൌ ݌ ∗ ߜ ௥௥ାఊ, 
ݏଷ ൌ ݌ ∗ ߜ ఊ௥ାఊ . The control group starts at steady state in the absence of the trial (α=0) with ݏଵ ൌ 1 െ ݌, 
ݏଶ ൌ ݌ ௥௥ାఊ and ݏଷ ൌ ݌
ఊ
௥ାఊ. The initial conditions for immediate progression and progression at the end of 
infection (where ߛ ൌ 0 and ܫሺݐሻ ൌ ܫଵሺݐሻ ൅ ܫଶሺݐሻ) are described as S(0)ൌ ݏଵ and ܫሺ0ሻ ൌ ݏଶ ൅ ݏଷ. 
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2. Maximum likelihood estimation of the fraction f of chlamydia infections 
progressing to PID (fMLE) 
The maximum likelihood estimate [1] of the fraction f of infected women who progress from chlamydia to 
PID is obtained by maximising the following likelihood L. We used subscript I in the likelihood to indicate 
the intervention group and subscript C for the control group. We assumed for both groups that the observed 
PID cases (oI, oC) are binomially distributed and that they are a mixture of cases caused by chlamydia and by 
other microorganisms. The probability for each woman to develop PID within the timeframe of one year is 
set to equal the overall cumulative incidence of PID cases after one year (eI, eC). 
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where Nj equals the number of women in each group. The derivations of eI and eC are explained in the 
method section of the main text. 
3. Akaike’s information criterion (AIC) 
The Akaike’s information criterion (AIC) is defined as  
 
ܣܫܥ ൌ െ2 logሺܮሻ ൅ 2݇ 
 
where L is the likelihood and k the number of estimated parameters in the model, k=1 for the model used in 
this study [2]. 
4. How incidence of PID accumulates in each type of progression 
To illustrate how incidence of PID accumulates from the start of infection, a hypothetical cohort of 
women who became infected at the same time is followed over time. In this hypothetical cohort, 
women can develop PID according to the three processes described in the main text. Figure A1 
shows the cumulative incidence of PID as a function of time since infection, using baseline values 
(see Table 1 in main text) and the maximum likelihood estimates (MLE) for the fraction 
progressing to PID ( ெ݂௅ா). We obtained the time point where half of the expected PID cases 
( ெ݂௅ா/2) have occurred (T50 in Table A1) and indicated them with black dots in Figure A1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
In the immediate progression scenario, the time point when half of the expected PID cases occurred 
is 0 days. This is an intuitive consequence of the progression without a delay.  
 
In the scenario with a constant daily risk of developing PID (constant progression) the cumulative 
incidence of PID is increasing fast in the beginning and flattens out (Figure A1). It takes 228 days 
until half of the expected PID cases are observed. In the progression at the end scenario, a similar 
behaviour for the cumulative incidence can be observed (Figure A1) and the half-value time (T50) is 
simply the half-life of infectious duration, i.e. 253 days (=ln(2)/r). 
 
Table A1 Time until half of expected PID cases 
occured 
Type of progression ࢌࡹࡸࡱ* T50† 
Immediate progression 8.3 % 0 days
Constant progression 9.9 % 228 days
Progression at the end 10.0 % 253 days
* MLE for fraction progressing to PID from Table 2. 
† Time point when half of the expected PID cases ( ெ݂௅ா/2) have 
occurred. 
PID, pelvic inflammatory disease; MLE, maximum likelihood 
estimate. 
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Figure A1 Illustration how incidence of PID accumulates in each type of progression. 
Cumulative incidence of PID following a hypothetical cohort of women who become 
infected at the same time, using baseline values and the maximum likelihood estimates 
for fraction progressing ( ெ݂௅ா): immediate progression (dashed line); constant 
progression (solid line); and progression at the end (dashed-dotted line). The black dots 
indicate when half of the expected PID cases occurred ( ெ݂௅ா/2). 
These values look similar because the duration until PID development is exponentially distributed 
in both scenarios but the definition of the duration until PID development becomes possible differs. 
In the progression at the end scenario, the duration until PID development equals the duration of the 
infection as PID develops just before natural clearance. In the constant progression, PID can 
develop throughout the infection which implies that some women will develop PID soon after 
infection whereas others will develop it very late in their infection. 
 
Despite the similarities in the results about T50, the two scenarios differ conceptually regarding the 
window of opportunity for screening to prevent PID. In the progression at the end scenario the time 
window for preventing PID is the whole infection period whereas in the constant progression 
scenario the window might be shorter than the duration of infection. 
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Figure A2 The maximum likelihood estimations for the fraction f 
of progression for the sensitivity analysis with 1000 parameter sets: 
immediate progression (A); constant progression (B); and 
progression at the end (C). The mean and the median of the 
maximum likelihood estimations are listed within each panel and 
the 95% credibility interval (CI) is shown (dashed line). 
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5. Result of multivariable sensitivity analysis 
We did a multivariable sensitivity analysis by sampling each model parameter and the proportion of PID 
cases caused by chlamydia 1000 times from the distributions in Table 1 in the main text. The maximum 
likelihood estimates for the fraction of women progressing to PID (f) were determined and the quantiles 
(0.025 and 0.975) were obtained as 95% credibility interval, see Figure A2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
6 
6. Varying mean time between start of infection and time point when 
progression to PID becomes possible 
For the sensitivity analysis we introduced a model framework which is similar to the constant 
progression scenario but allows varying the mean time between start of infection and the time point 
when progression to PID becomes possible. We used the same model structure as described in the 
main text with two stages of infections (I1, I2) but in doing so the interpretation of I2 has changed.  
 
In stage I1 women are infected without having PID but those who make the transition to stage I2 
with rate γ are now at risk to develop PID, i.e. upon entering I2 a fraction ሚ݂ will develop PID. Stage 
I2 is therefore a mixture of infected women with PID ( ሚ݂) and without PID (1- ሚ݂) and consequently 
incidence of chlamydial PID equals ሚ݂ߛܫଵ. 
 
The introduction of the new parameter ሚ݂, fraction progressing to PID at transition to I2, is needed to 
specify the fraction of women who develop PID at the time point when PID becomes possible. This 
differs to the fraction ݂ in that ሚ݂ refers only to the women who remain infected at the time point at 
which progression to PID becomes possible. The interpretation of the fraction ݂ is the same as in 
the three types of progression of the main text, i.e. ݂ is the fraction of all women infected that will 
develop PID in the absence of an intervention The relationship between ݂ and ሚ݂ is 
 
݂ ൌ ሚ݂ ߛݎ ൅ ߛ 
 
where ఊ௥ାఊ is the probability to make the transition from I1 to I2, r is the clearence rate of the 
infection, and 1/ߛ is the mean time between start of infection and the time point when progression 
to PID becomes possible. The relationship implies for a short mean duration until progression to 
PID becomes possible (i.e. small 1/ߛ) that ሚ݂ will be similar to ݂. But for increasing 1/ߛ follows that 
ሚ݂ has to increase too as women will have recovered without making the transition to I2. Note, there 
is a maximum value for the mean time 1/ߛ because the conditions ሚ݂ ൑ 100% and ݂ ൑ 100% have 
to be fulfilled. 
 
The scenario of immediate progression can be approximated with 1/ߛ ൎ	0 which implies that ሚ݂ ൎ ݂; 
and the constant progression scenario corresponds to the situation with 	 ሚ݂=100%. The scenario with 
progression at the end of the infection cannot be approximated in this model framework. 
 
We could not fit both unknown parameters (γ, ሚ݂) to the trial data as we have only two data points. 
We derived the maximum likelihood estimate (MLE) for the fraction of infected women developing 
PID at the transition to I2 ( ሚ݂) for different values for the mean duration (1/γ), using the observed 
cumulative incidences from the trial and the baseline values for all other paramters (see Table 1 in 
the main text). We varied the mean duration (1/γ) between 0 years and a maximum of 9.1 years, 
which is a consequence of the condition ሚ݂ ൑ 100%. For each mean duration value we obtained 
MLE of fraction ሚ݂, the corresponding MLE of fraction f (using the relationship stated above), and 
the AIC value. We also obtained the cumulative incidence of PID after one year for the intervention 
group and the control group. 
 
The best fitting values for the fraction of all infected women developing PID ( ெ݂௅ா) are between 
8.3% and 9.9% for varying the mean time between start of infection and the time point when 
progression to PID becomes possible (dashed line in panel A of Figure A3). Note, the estimates are 
in the same range as the three types of progression in the main text. The corresponding cumulative 
incidence of PID after one year are very similar for the intervention and control group if the mean 
time between start of infection and progression is short but diverge with increasing mean duration 
7 
(panel B). The AIC values are similar for the explored ranges of the mean duration (note the narrow 
scale of the y-axis in panel C), But the best fit model converges to the scenario when PID develops 
at a constant rate throughout the infection, i.e. ሚ݂ ൌ 100%. 
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Figure A3 Varying mean time between start of infection and time point when progression to PID becomes 
possible (1/γ), using baseline values. Panel A, maximum likelihood estimators (MLE) for ሚ݂ெ௅ா respectively 
ெ݂௅ா; panel B, corresponding cumulative incidence of PID after one year for the MLE values for intervention 
group (solid line) and control group (dashed line); panel C, corresponding Akaike’s Information Criterion 
(AIC) values for the MLE values. In all panels, the black dot indicates the approximation of the immediate 
progression and the black quadrate corresponds to the scenario of constant progression. 
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